Skip to content
AKAVA THERAPEUTICS
  • About Us
    • Management Team
    • Scientific Advisory Board
    • Board of Directors
  • Pipeline
    • Protein Aggregation Degrader
    • Neuronal Nitric Oxide Synthase Inhibitors
    • Ornithine Aminotransferase Inactivator
  • Therapeutic Areas
  • Science
    Behind the Discoveries
    • AKV9, Protein Aggregation Degrader
    • What Makes AKV9 Different?
    • Neuronal Nitric Oxide Synthase Inhibitors
    • Ornithine Aminotransferase Inactivators
  • Partners &
    Collaborators
  • News
  • Publications
  • Careers
  • Contact Us
Menu
  •          
  • Print

pipeline

Search Results for:

AKAVA THERAPEUTICS > Draw Attention > pipeline
AKAVA THERAPEUTICS > Draw Attention > pipeline
pipeline
  • About Us
  • Pipeline
  • Therapeutic Areas
  • Science Behind the Discoveries
  • Partners & Collaborators
  • News
  • Publications
  • Careers
  • Contact Us
  • Site Map
  • Privacy Policy

AKAVA Therapeutics is developing first-in-class small molecule therapeutics that inhibit adverse effects of protein aggregation, inhibit enzymes and inhibit cancer for a variety of neurodegenerative diseases and cancers.

© Akava Therapeutics Inc. All Rights Reserved
Website by Axxiem
Scroll to top